Mass General Brigham

What is "The Path to Lifelong Genomic Medicine"? Robert Green, MD, MPH, a renowned physician-scientist at Mass General Brigham and Professor of Medicine (Genetics) at Harvard Medical School, will deliver the opening keynote at the upcoming Precision Medicine and the Future of Genomics 2024 Summit in Doha, Qatar on December 3. Dr. Green is widely recognized for his leadership in the MedSeq and BabySeq Projects, which have provided crucial early data on the clinical utility and cost-effectiveness of comprehensive genomic sequencing in adults and newborns. Learn more: https://spklr.io/6043xI57 #PrecisionMedicine #FutureOfGenomics #PMFG2024

At this time of year, we take a moment to pause and reflect on the people or moments that make our lives memorable, easier, or a little more enjoyable. In anticipation of Thanksgiving, Mass General Brigham research community members share what they are most grateful for. https://spklr.io/6047xse7

Two weeks ago, Mass General Brigham leaders traveled to the Dominican Republic to attend and support CEDIMAT’s XIX Jornada Médico-Científica Dr. Juan M. Taveras. We were thrilled to sponsor and be part of this important medical innovation conference and connect with healthcare professionals from the Dominican Republic and Latin America. Our physicians, George Molina, MD, MPH, and Luis Suarez, MD, participated in the conference presenting advances in colorectal liver cancer metastasis and peripheral vascular disease. Thank you CEDIMAT, and to everyone who joined us at our booth. We are looking forward to continued collaboration in medical innovation. Learn more about International Patient Services at Mass General Brigham: https://spklr.io/6042xvHm Our Mass General Brigham team featured (left to right): Photo #1: Luis Suarez, MD; George Molina, MD, MPH; Carmen Alvarez and Karim Talleh, MHA from our International Patient Services team. Photo #2: Luis Suarez, MD Photo #3: George Molina, MD, MPH

IgG4-RD is a rare multiorgan immune-mediated disorder with no approved therapy. A team led by Mass General Brigham researchers found a new treatment reduces symptoms by 87%. Learn more about this groundbreaking research: https://spklr.io/6045xcl7

Mass General Brigham Home Hospital improves patient quality and experience when they can recover at home. Healthcare options in-home continue to grow, and Congress can help ensure the future of these types of programs by extending necessary regulations. Learn more in The Washington Post.

Enhance your skills with our multidisciplinary CME program focused on musculoskeletal ultrasound! Ideal for orthopedics, sports medicine, rheumatology, and more. Join expert physicians from Massachusetts General Hospital and Spaulding Rehabilitation Hospital. Register now: https://spklr.io/6045xcgT

During the annual Boston Bruins Academy Coaching Symposium, Stephen Durant, Ed.D., staff psychologist for the Boston Bruins and co-director of the Massachusetts General Hospital Sports Psychology Program, shared insights on the biological and psychological signs of a healthy adolescent athlete's mind. He highlighted warning signs of mental health challenges, emphasizing the importance of recognizing and addressing them. Stephen also discussed the value of gratitude and the principle that pain and suffering can be overcome—with support from others. The Boston Bruins Coaching Symposium presented by Mass General Brigham, in partnership with Massachusetts Hockey Inc., is a marquee event that brings together coaches from across New England. It offers participants the chance to learn from USA Hockey-certified experts and gain valuable insights to enhance their coaching skills. Photos via Boston Bruins

Early signs of Alzheimer's disease, like memory loss, confusion, and mood changes, can be subtle but significant. Learn more about this disease and as a system, Mass General Brigham will continue to work toward breakthroughs in treatment and care. https://spklr.io/6044xVuQ #EndAlz #AlzheimersAwareness

As an industry leader in sustainable healthcare delivery, we are committed to minimizing our environmental impact. We are joining Harvard University, Massachusetts Institute of Technology, and PowerOptions, Inc. to collaborate with Apex Clean Energy to enable two new renewable energy facilities and purchase an estimated 1.3 million megawatt-hours of renewable electricity annually by 2026. Beyond generating tangible environmental benefits, the two projects will create approximately $64 million in tax revenue for their communities, 750 jobs during construction, and a new and long-term source of income for local farmers and landowners, totaling $100 million. Learn more about this collaboration: https://spklr.io/6041x5AW

Mass Eye and Ear researchers conducted a clinical trial of an oral medication, sodium oxybate—commonly used for narcolepsy—to treat laryngeal dystonia, an often-debilitating condition that affects speech. Inspired by patients who noticed their symptoms eased after drinking alcohol, researchers explored how this medication, which mimics some alcohol effects on the brain, could help. The results? Voice symptoms improved by an average of 41% in patients with alcohol-responsive laryngeal dystonia. Study lead author Kristina Simonyan, MD, PhD, Dr med, vice chair for clinical research and director of laryngology research in the Department of Otolaryngology–Head and Neck Surgery at Mass Eye and Ear, shares insights into this breakthrough in the Annals of Neurology. Learn about this innovative step forward in treating speech-related conditions: https://spklr.io/6041xbOX.